Abeona Therapeutics ABEO
NASDAQ ABEO
$2.60 +0.18 (+7.44%)
At close: Nov 16, 2026 · 4:00 PM EST

Abeona Therapeutics (ABEO) Non Operating Interest Expenses (2009 - 2026)

Updated

Abeona Therapeutics (ABEO) recorded Non Operating Interest Expenses of $557,000 in Q3 2026, down 38.2% from $901,000 a year earlier and down 20.0% from the prior quarter.

Analysis

Abeona Therapeutics (ABEO) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends

On a TTM basis, Abeona Therapeutics' Non Operating Interest Expenses came in at $2.97 million as of Sep 30, 2026, down 24.7% year-over-year; for FY2025, it was $3.74 million, down 11.1% from FY2024.

  • Annual Non Operating Interest Expenses has a five-year compound annual growth rate of -1.9% (FY2020 to FY2025).
  • Across earlier years, Non Operating Interest Expenses came in at $4.21 million in FY2024 (+906.7%), $418,000 in FY2023 (-43.2%), $736,000 in FY2022 (-79.9%) and $3.66 million in FY2021 (-11.2%).
  • The Q3 2026 figure is the lowest quarterly Non Operating Interest Expenses since Q4 2023.
  • On a year-over-year basis, Non Operating Interest Expenses has declined for six consecutive quarters, with growth averaging 96.0% over the last eight quarters.
  • Peak year-over-year performance for Non Operating Interest Expenses in the last five years was growth of 949.5% in Q3 2024, against a decline of 96.2% in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $696,000 (Q2 2026), $830,000 (Q1 2026) and $884,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 217.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -477.00 Mn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 269.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Abeona Therapeutics 149.28 Mn -492.16 Mn 7.78 Mn 557,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 557,000.00
Jun 30, 2026 696,000.00
Mar 31, 2026 830,000.00
Dec 31, 2025 884,000.00
Sep 30, 2025 901,000.00
Jun 30, 2025 957,000.00
Mar 31, 2025 998,000.00
Dec 31, 2024 1.08 Mn
Sep 30, 2024 1.10 Mn
Jun 30, 2024 1.07 Mn
Mar 31, 2024 952,000.00
Dec 31, 2023 109,000.00
Sep 30, 2023 105,000.00
Jun 30, 2023 103,000.00
Mar 31, 2023 101,000.00
Dec 31, 2022 178,000.00
Sep 30, 2022 157,000.00
Jun 30, 2022 200,000.00
Mar 31, 2022 201,000.00
Dec 31, 2021 53,000.00
API Access

Abeona Therapeutics Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ABEO&period=max&api_key=YOUR_API_KEY